Q-omics provides the consensus-scored UPK3BL2 profile across patient tissues and cancer cell-line models. Additionally, UPK3BL2 RNA expression shows 3,723 significant protein co-abundance associations, with the highest sampling consensus in BRCA.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for UPK3BL2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with UPK3BL2 in patient tissues and cancer cell lines. In patient samples, UPK3BL2 shows the broadest associations at the RNA and protein expression levels, with BRCA recurring as the lineage with the largest associated feature set. In cancer cell lines, UPK3BL2 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BLOOD_Leukemia, while CRISPR and shRNA rows add functional-dependency signals in SOFT_TISSUE.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	3,723	BRCA (1104)	view →
Function (mass-spec)	460	BRCA (293)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼shRNA
RNA	1,505	BLOOD_Leukemia (508)	view →
shRNA	1,153	SOFT_TISSUE (139)	view →